首页 > 最新文献

Minimally Invasive Therapy & Allied Technologies最新文献

英文 中文
Robotic versus laparoscopic surgery for colorectal cancer in older patients: a systematic review and meta-analysis. 老年患者结直肠癌机器人手术与腹腔镜手术:系统回顾与荟萃分析。
IF 1.7 4区 医学 Q2 SURGERY Pub Date : 2025-02-01 Epub Date: 2024-05-31 DOI: 10.1080/13645706.2024.2359705
Xinyu Wang, Rui Ma, Tiewei Hou, Hao Xu, Cheng Zhang, Chun Ye

Objective: Robotic surgery is being increasingly used for colorectal cancer surgery. However, its utility versus laparoscopic surgery in older patients is unclear. We systematically examined evidence to assess the differences in short-term outcomes of robotic versus laparoscopic surgery for colorectal cancer in older patients.

Material and methods: Comparative studies published on PubMed, Web of Science, Embase, and CENTRAL databases were searched up to August 30th, 2023.

Results: Seven studies totaling 14,043 patients were included. Meta-analysis showed no difference in the operation time between the robotic and laparoscopic groups. Meta-analysis of ClavienDindo complications showed no difference between the robotic and laparoscopic groups for grades I and II or grades III and IV complications. Similarly, conversion to open surgery, reoperation rates and length of hospital stay were not significantly different between the two groups. Readmission rates and mortality rates were significantly lower with robotic surgery.

Conclusion: This first meta-analysis comparing outcomes of robotic and laparoscopic surgery in older colorectal cancer patients shows that both approaches result in no difference in operating time, complication rates, conversion to open surgery, reoperation rates, and LOS. Scarce data shows that mortality and readmission rates may be lower with robotic surgery.

目的:机器人手术越来越多地被用于结直肠癌手术。然而,机器人手术与腹腔镜手术在老年患者中的应用尚不明确。我们系统地研究了相关证据,以评估老年患者结直肠癌机器人手术与腹腔镜手术短期疗效的差异:检索了截至2023年8月30日发表在PubMed、Web of Science、Embase和CENTRAL数据库中的对比研究:结果:共纳入七项研究,共计 14,043 名患者。Meta分析显示,机器人组和腹腔镜组的手术时间没有差异。ClavienDindo并发症的元分析显示,机器人组和腹腔镜组在I级和II级并发症或III级和IV级并发症方面没有差异。同样,两组患者转为开腹手术、再次手术率和住院时间也无明显差异。再次入院率和死亡率则明显低于机器人手术:这项首次比较老年结直肠癌患者机器人手术和腹腔镜手术结果的荟萃分析表明,两种方法在手术时间、并发症发生率、转为开腹手术率、再次手术率和住院时间方面均无差异。稀少的数据显示,机器人手术的死亡率和再入院率可能更低。
{"title":"Robotic versus laparoscopic surgery for colorectal cancer in older patients: a systematic review and meta-analysis.","authors":"Xinyu Wang, Rui Ma, Tiewei Hou, Hao Xu, Cheng Zhang, Chun Ye","doi":"10.1080/13645706.2024.2359705","DOIUrl":"10.1080/13645706.2024.2359705","url":null,"abstract":"<p><strong>Objective: </strong>Robotic surgery is being increasingly used for colorectal cancer surgery. However, its utility versus laparoscopic surgery in older patients is unclear. We systematically examined evidence to assess the differences in short-term outcomes of robotic versus laparoscopic surgery for colorectal cancer in older patients.</p><p><strong>Material and methods: </strong>Comparative studies published on PubMed, Web of Science, Embase, and CENTRAL databases were searched up to August 30th, 2023.</p><p><strong>Results: </strong>Seven studies totaling 14,043 patients were included. Meta-analysis showed no difference in the operation time between the robotic and laparoscopic groups. Meta-analysis of ClavienDindo complications showed no difference between the robotic and laparoscopic groups for grades I and II or grades III and IV complications. Similarly, conversion to open surgery, reoperation rates and length of hospital stay were not significantly different between the two groups. Readmission rates and mortality rates were significantly lower with robotic surgery.</p><p><strong>Conclusion: </strong>This first meta-analysis comparing outcomes of robotic and laparoscopic surgery in older colorectal cancer patients shows that both approaches result in no difference in operating time, complication rates, conversion to open surgery, reoperation rates, and LOS. Scarce data shows that mortality and readmission rates may be lower with robotic surgery.</p>","PeriodicalId":18537,"journal":{"name":"Minimally Invasive Therapy & Allied Technologies","volume":" ","pages":"35-43"},"PeriodicalIF":1.7,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141179982","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
4DryField vs. hyalobarrier gel for preventing the recurrence of intrauterine adhesions - a pilot study. 4DryField 与 hyalobarrier 凝胶在预防宫腔内粘连复发方面的对比--一项试点研究。
IF 1.7 4区 医学 Q2 SURGERY Pub Date : 2025-02-01 Epub Date: 2024-05-21 DOI: 10.1080/13645706.2024.2351829
Zdenka Lisa, Adela Richtarova, Kristyna Hlinecka, Barbora Boudova, David Kuzel, Michael Fanta, Michal Mara

Introduction: This was a single-center pilot study that sought to describe an innovative use of 4DryField® PH (premix) for preventing the recurrence of intrauterine adhesions (IUAs) after hysteroscopic adhesiolysis in patients with Asherman's syndrome (AS).

Material and methods: Twenty-three patients with AS were enrolled and 20 were randomized (1:1 ratio) to intrauterine application of 4DryField® PH (n = 10) or Hyalobarrier® gel (n = 10) in a single-blind manner. We evaluated IUAs (American Fertility Society [AFS] score) during initial hysteroscopy and second-look hysteroscopy one month later. Patients completed a follow-up symptoms questionnaire three and reproductive outcomes questionnaire six months later.

Results: The demographic and clinical characteristics, as well as severity of IUAs, were comparable in both groups. The mean initial AFS score was 9 and 8.5 in the 4DryField® PH and Hyalobarrier® gel groups, respectively (p = .476). There were no between-group differences in AFS progress (5.9 vs. 5.6, p = .675), need for secondary adhesiolysis (7 vs. 7 patients, p = 1), and the follow-up outcomes.

Conclusion: 4DryField® PH could be a promising antiadhesive agent for preventing the recurrence of IUAs, showing similar effectiveness and safety to Hyalobarrier® gel. Our findings warrant prospective validation in a larger clinical trial.

Clinical trial registry number: ISRCTN15630617.

简介:这是一项单中心试点研究,旨在描述4DryField® PH(预混剂)在阿舍曼氏综合征(AS)患者宫腔镜粘连溶解术后预防宫腔内粘连(IUAs)复发的创新应用:23名AS患者被纳入研究,20名患者被随机(1:1的比例)在宫腔内应用4DryField® PH(n = 10)或Hyalobarrier®凝胶(n = 10)。我们在初次宫腔镜检查和一个月后的第二次宫腔镜检查中对 IUAs(美国生育协会 [AFS] 评分)进行了评估。患者在三个月后填写了随访症状问卷,六个月后填写了生殖结果问卷:结果:两组患者的人口统计学和临床特征以及 IUAs 的严重程度相当。4DryField® PH 组和 Hyalobarrier® 凝胶组的初始 AFS 平均得分分别为 9 分和 8.5 分(p = .476)。在 AFS 进展(5.9 vs. 5.6,p = .675)、二次粘连溶解需求(7 vs. 7 名患者,p = 1)和随访结果方面没有组间差异:4DryField®PH可能是一种很有前景的预防IUA复发的抗粘连剂,其有效性和安全性与Hyalobarrier®凝胶相似。临床试验登记号:ISRCTN15630617。
{"title":"4DryField vs. hyalobarrier gel for preventing the recurrence of intrauterine adhesions - a pilot study.","authors":"Zdenka Lisa, Adela Richtarova, Kristyna Hlinecka, Barbora Boudova, David Kuzel, Michael Fanta, Michal Mara","doi":"10.1080/13645706.2024.2351829","DOIUrl":"10.1080/13645706.2024.2351829","url":null,"abstract":"<p><strong>Introduction: </strong>This was a single-center pilot study that sought to describe an innovative use of 4DryField® PH (premix) for preventing the recurrence of intrauterine adhesions (IUAs) after hysteroscopic adhesiolysis in patients with Asherman's syndrome (AS).</p><p><strong>Material and methods: </strong>Twenty-three patients with AS were enrolled and 20 were randomized (1:1 ratio) to intrauterine application of 4DryField® PH (<i>n</i> = 10) or Hyalobarrier<sup>®</sup> gel (<i>n</i> = 10) in a single-blind manner. We evaluated IUAs (American Fertility Society [AFS] score) during initial hysteroscopy and second-look hysteroscopy one month later. Patients completed a follow-up symptoms questionnaire three and reproductive outcomes questionnaire six months later.</p><p><strong>Results: </strong>The demographic and clinical characteristics, as well as severity of IUAs, were comparable in both groups. The mean initial AFS score was 9 and 8.5 in the 4DryField<sup>®</sup> PH and Hyalobarrier<sup>®</sup> gel groups, respectively (<i>p</i> = .476). There were no between-group differences in AFS progress (5.9 vs. 5.6, <i>p</i> = .675), need for secondary adhesiolysis (7 vs. 7 patients, <i>p</i> = 1), and the follow-up outcomes.</p><p><strong>Conclusion: </strong>4DryField<sup>®</sup> PH could be a promising antiadhesive agent for preventing the recurrence of IUAs, showing similar effectiveness and safety to Hyalobarrier<sup>®</sup> gel. Our findings warrant prospective validation in a larger clinical trial.</p><p><strong>Clinical trial registry number: </strong>ISRCTN15630617.</p>","PeriodicalId":18537,"journal":{"name":"Minimally Invasive Therapy & Allied Technologies","volume":" ","pages":"71-77"},"PeriodicalIF":1.7,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141076282","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Partial splenic embolization with embosphere microspheres (700-900 µm) for the treatment of hypersplenism: comparison of selective superior splenic artery embolization and inferior splenic artery embolization. 使用栓塞球微球(700-900 微米)进行部分脾栓塞治疗脾功能亢进:选择性脾上动脉栓塞与脾下动脉栓塞的比较。
IF 1.7 4区 医学 Q2 SURGERY Pub Date : 2025-02-01 Epub Date: 2024-04-12 DOI: 10.1080/13645706.2024.2339917
Chao Ma, Yan Wang, Heng Zhang, Feng Duan, Mao-Qiang Wang

Objective: To compare clinical outcomes of superior versus inferior splenic artery embolization in partial splenic embolization (PSE) and identify predictors of major complications.

Material and methods: This retrospective case-control study included 73 patients who underwent PSE between May 2005 and April 2021. They were divided into two groups: the superior and middle splenic artery embolization group (Group A, n = 37) and the inferior and middle splenic artery embolization group (Group B, n = 36). Outcome differences and major complications between the groups were assessed. Logistic regression was used to analyze potential predictors of major complications, and the optimal cutoff value for splenic embolization rates was determined using the Youden index.

Results: There were no significant differences in laboratory and radiological outcomes between the two groups. Group A had a significantly lower incidence of major complications than Group B (p = 0.049), a lower Visual Analog Scale (VAS) score for pain (p = 0.036), and a shorter hospital stay (p = 0.022). Independent risk factors for major complications included inferior and middle splenic artery embolization (odds ratio [OR] = 3.672; 95% confidence interval [CI] = 1.028-13.120; p = 0.045) and a higher spleen embolization rate (OR = 1.108; 95% CI = 1.003-1.224; p = 0.044). The optimal cutoff for spleen embolization rate to predict major complications was 59.93% (sensitivity 77.8%, specificity 63.6%).

Conclusion: Using 500-700 µm microspheres for PSE, targeting the middle and superior splenic artery yields similar effects to targeting the middle and inferior artery, but results in lower rates of major complications and shorter hospital stays. To effectively minimize the risk of major complications, the embolization rate should be kept below 59.93%, regardless of the target vessel.

目的比较部分脾栓塞术(PSE)中上脾动脉栓塞与下脾动脉栓塞的临床效果,并确定主要并发症的预测因素。材料与方法:这项回顾性病例对照研究纳入了 2005 年 5 月至 2021 年 4 月间接受部分脾动脉栓塞术的 73 例患者。他们被分为两组:脾上、中动脉栓塞组(A 组,n = 37)和脾下、中动脉栓塞组(B 组,n = 36)。对两组之间的结果差异和主要并发症进行了评估。使用逻辑回归分析主要并发症的潜在预测因素,并使用尤登指数确定脾栓塞率的最佳临界值。结果两组患者的实验室和放射学结果无明显差异。A 组的主要并发症发生率明显低于 B 组(P = 0.049),疼痛视觉模拟量表(VAS)评分较低(P = 0.036),住院时间较短(P = 0.022)。主要并发症的独立风险因素包括下脾动脉和中脾动脉栓塞(几率比 [OR] = 3.672;95% 置信区间 [CI] = 1.028-13.120;P = 0.045)和较高的脾脏栓塞率(OR = 1.108;95% CI = 1.003-1.224;P = 0.044)。脾脏栓塞率预测主要并发症的最佳临界值为 59.93%(敏感性 77.8%,特异性 63.6%)。结论使用 500-700 µm 的微球进行 PSE,以脾中线和上动脉为靶点与以脾中线和下动脉为靶点的效果相似,但主要并发症发生率较低,住院时间较短。为有效降低主要并发症的风险,无论采用哪种靶血管,栓塞率都应保持在 59.93% 以下。
{"title":"Partial splenic embolization with embosphere microspheres (700-900 µm) for the treatment of hypersplenism: comparison of selective superior splenic artery embolization and inferior splenic artery embolization.","authors":"Chao Ma, Yan Wang, Heng Zhang, Feng Duan, Mao-Qiang Wang","doi":"10.1080/13645706.2024.2339917","DOIUrl":"10.1080/13645706.2024.2339917","url":null,"abstract":"<p><strong>Objective: </strong>To compare clinical outcomes of superior versus inferior splenic artery embolization in partial splenic embolization (PSE) and identify predictors of major complications.</p><p><strong>Material and methods: </strong>This retrospective case-control study included 73 patients who underwent PSE between May 2005 and April 2021. They were divided into two groups: the superior and middle splenic artery embolization group (Group A, <i>n</i> = 37) and the inferior and middle splenic artery embolization group (Group B, <i>n</i> = 36). Outcome differences and major complications between the groups were assessed. Logistic regression was used to analyze potential predictors of major complications, and the optimal cutoff value for splenic embolization rates was determined using the Youden index.</p><p><strong>Results: </strong>There were no significant differences in laboratory and radiological outcomes between the two groups. Group A had a significantly lower incidence of major complications than Group B (<i>p</i> = 0.049), a lower Visual Analog Scale (VAS) score for pain (<i>p</i> = 0.036), and a shorter hospital stay (<i>p</i> = 0.022). Independent risk factors for major complications included inferior and middle splenic artery embolization (odds ratio [OR] = 3.672; 95% confidence interval [CI] = 1.028-13.120; <i>p</i> = 0.045) and a higher spleen embolization rate (OR = 1.108; 95% CI = 1.003-1.224; <i>p</i> = 0.044). The optimal cutoff for spleen embolization rate to predict major complications was 59.93% (sensitivity 77.8%, specificity 63.6%).</p><p><strong>Conclusion: </strong>Using 500-700 µm microspheres for PSE, targeting the middle and superior splenic artery yields similar effects to targeting the middle and inferior artery, but results in lower rates of major complications and shorter hospital stays. To effectively minimize the risk of major complications, the embolization rate should be kept below 59.93%, regardless of the target vessel.</p>","PeriodicalId":18537,"journal":{"name":"Minimally Invasive Therapy & Allied Technologies","volume":" ","pages":"61-70"},"PeriodicalIF":1.7,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140874702","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The vaginal route for minimally invasive surgery: a practical guide for general surgeons. 微创手术的阴道路径:普通外科医生实用指南。
IF 1.7 4区 医学 Q2 SURGERY Pub Date : 2025-02-01 Epub Date: 2024-06-08 DOI: 10.1080/13645706.2024.2359707
Matteo Pavone, Lise Lecointre, Barbara Seeliger, Riccardo Oliva, Cherif Akladios, Denis Querleu, Giovanni Scambia, Jacques Marescaux, Antonello Forgione

Introduction: Vaginal approaches have become routine in the field of gynecologic surgery, whereas in general surgery vaginal wall transection is an infrequent practice typically reserved for extensive tumor resections. Approximately two decades ago, natural orifice transluminal endoscopic surgery (NOTES) revolutionized conventional boundaries by accessing the peritoneal cavity transorally, transrectally, or transvaginally, enabling general surgery without visible scars. Although transvaginal approaches have been successfully used for various abdominal procedures by general surgeons, a gap remains in comprehensive training to fully exploit the potential of this route.

Material and methods: PubMed, Google Scholar, and Scopus databases were searched to retrieve relevant articles illustrating how general surgeons can adeptly manage vaginal approaches.

Results: The article presents a practical framework for general surgeons to execute a complete vaginal approach, addressing the management of vaginal specimen extraction and vaginal cuff closure, even in the absence of an experienced gynecologist.

Conclusion: The evolution of abdominal surgery is moving towards less invasive techniques, emphasizing the importance of understanding the nuances and challenges associated with the vaginal route. This approach is linked to minimal oncological, sexual, and infective complications, and to the absence of pregnancy-related complications. Such knowledge becomes increasingly crucial, particularly with the renewed demand for transvaginal access in robot-assisted NOTES procedures.

简介:在妇科手术领域,阴道手术已成为常规手术,而在普通外科,阴道壁横断通常只用于大面积肿瘤切除术,并不常见。大约二十年前,自然孔腔内镜手术(NOTES)通过经腹、经直肠或经阴道进入腹腔,实现了无明显疤痕的普外科手术,从而彻底改变了传统的手术界限。尽管普外科医生已成功将经阴道方法用于各种腹部手术,但在充分挖掘这一途径潜力的综合培训方面仍存在差距:搜索了PubMed、Google Scholar和Scopus数据库,以检索相关文章,说明普外科医生如何能够熟练地管理阴道入路:结果:文章为普外科医生提供了一个实用的框架,即使在没有经验丰富的妇科医生的情况下,也能实施完整的阴道手术,解决阴道标本提取和阴道袖带闭合的管理问题:腹部手术的发展正朝着微创技术的方向迈进,这强调了了解阴道途径的细微差别和相关挑战的重要性。这种方法可将肿瘤、性和感染并发症降至最低,而且不会出现与妊娠有关的并发症。这些知识变得越来越重要,尤其是在机器人辅助NOTES手术中,对经阴道入路的需求再次增加。
{"title":"The vaginal route for minimally invasive surgery: a practical guide for general surgeons.","authors":"Matteo Pavone, Lise Lecointre, Barbara Seeliger, Riccardo Oliva, Cherif Akladios, Denis Querleu, Giovanni Scambia, Jacques Marescaux, Antonello Forgione","doi":"10.1080/13645706.2024.2359707","DOIUrl":"10.1080/13645706.2024.2359707","url":null,"abstract":"<p><strong>Introduction: </strong>Vaginal approaches have become routine in the field of gynecologic surgery, whereas in general surgery vaginal wall transection is an infrequent practice typically reserved for extensive tumor resections. Approximately two decades ago, natural orifice transluminal endoscopic surgery (NOTES) revolutionized conventional boundaries by accessing the peritoneal cavity transorally, transrectally, or transvaginally, enabling general surgery without visible scars. Although transvaginal approaches have been successfully used for various abdominal procedures by general surgeons, a gap remains in comprehensive training to fully exploit the potential of this route.</p><p><strong>Material and methods: </strong>PubMed, Google Scholar, and Scopus databases were searched to retrieve relevant articles illustrating how general surgeons can adeptly manage vaginal approaches.</p><p><strong>Results: </strong>The article presents a practical framework for general surgeons to execute a complete vaginal approach, addressing the management of vaginal specimen extraction and vaginal cuff closure, even in the absence of an experienced gynecologist.</p><p><strong>Conclusion: </strong>The evolution of abdominal surgery is moving towards less invasive techniques, emphasizing the importance of understanding the nuances and challenges associated with the vaginal route. This approach is linked to minimal oncological, sexual, and infective complications, and to the absence of pregnancy-related complications. Such knowledge becomes increasingly crucial, particularly with the renewed demand for transvaginal access in robot-assisted NOTES procedures.</p>","PeriodicalId":18537,"journal":{"name":"Minimally Invasive Therapy & Allied Technologies","volume":" ","pages":"78-87"},"PeriodicalIF":1.7,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141293555","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
3-Fr steerable microcatheter system via the upper limb artery in RADPLAT for right maxillary cancer. 在 RADPLAT 中通过上肢动脉的 3-Fr 可转向微导管系统治疗右上颌骨癌。
IF 1.7 4区 医学 Q2 SURGERY Pub Date : 2025-02-01 Epub Date: 2024-05-28 DOI: 10.1080/13645706.2024.2359718
Masao Takahashi, Ken Nakazawa, Yoko Usami, Yuki Natsuyama, Yuichi Tsukamoto, Jun Suzuki, Shiho Asami, Hitoshi Inoue, Satoko Matsumura, Mitsuhiko Nakahira, Tetsu Saito, Shingo Kato, Yoshitaka Okada, Hiroyuki Tajima, Eito Kozawa, Yasutaka Baba

Background: To evaluate the efficacy of a catheter system using a 3-Fr sheath with a steerable microcatheter through right upper limb artery access for superselective intra-arterial cisplatin infusion and concomitant radiotherapy (RADPLAT) to treat right maxillary sinus squamous cell carcinoma (MS-SCC).

Material and methods: We retrospectively studied 46 sessions in eight patients treated between November 2020 and February 2023 using the catheter system briefly described below. A 3-Fr sheath was inserted into the distal radial, conventional radial, or brachial arteries. A coaxial catheter system with a 2.9-Fr steerable microcatheter and a 1.9-Fr microcatheter was advanced into the brachiocephalic artery. The right common carotid artery was selected by bending the tip of the steerable microcatheter. Coil embolization and intra-arterial cisplatin infusion after selecting each external carotid artery branch were achieved using this catheter system.

Results: Cisplatin infusion and coil embolization were successful in all sessions. Arterial occlusion at the sheath insertion sites was found in 29.4% (5/17) of the distal radial arteries and 33.3% (3/9) of the conventional radial arteries. No other major complications were observed during the procedure.

Conclusion: Using a 3-Fr catheter system with a steerable microcatheter through right upper limb artery access is a feasible method for RADPLAT in treating right MS-SCC.

背景:材料与方法:我们回顾性研究了2020年11月至2023年2月期间使用导管系统治疗8例患者的46次疗程:我们回顾性研究了2020年11月至2023年2月期间使用导管系统对8名患者进行的46次治疗,简要介绍如下。在桡动脉远端、常规桡动脉或肱动脉中插入一个 3 英尺长的鞘。将带有 2.9-Fr 可转向微导管和 1.9-Fr 微导管的同轴导管系统推进肱脑动脉。通过弯曲可转向微导管的尖端,选择了右侧颈总动脉。在选择每个颈外动脉分支后,使用该导管系统实现了线圈栓塞和顺铂动脉内输注:结果:所有疗程的顺铂输注和线圈栓塞均获得成功。29.4%(5/17)的桡动脉远端和33.3%(3/9)的常规桡动脉鞘插入部位出现动脉闭塞。手术期间未发现其他重大并发症:结论:通过右上肢动脉入路使用带有可转向微导管的 3-Fr 导管系统是治疗右侧 MS-SCC 的一种可行的 RADPLAT 方法。
{"title":"3-Fr steerable microcatheter system via the upper limb artery in RADPLAT for right maxillary cancer.","authors":"Masao Takahashi, Ken Nakazawa, Yoko Usami, Yuki Natsuyama, Yuichi Tsukamoto, Jun Suzuki, Shiho Asami, Hitoshi Inoue, Satoko Matsumura, Mitsuhiko Nakahira, Tetsu Saito, Shingo Kato, Yoshitaka Okada, Hiroyuki Tajima, Eito Kozawa, Yasutaka Baba","doi":"10.1080/13645706.2024.2359718","DOIUrl":"10.1080/13645706.2024.2359718","url":null,"abstract":"<p><strong>Background: </strong>To evaluate the efficacy of a catheter system using a 3-Fr sheath with a steerable microcatheter through right upper limb artery access for superselective intra-arterial cisplatin infusion and concomitant radiotherapy (RADPLAT) to treat right maxillary sinus squamous cell carcinoma (MS-SCC).</p><p><strong>Material and methods: </strong>We retrospectively studied 46 sessions in eight patients treated between November 2020 and February 2023 using the catheter system briefly described below. A 3-Fr sheath was inserted into the distal radial, conventional radial, or brachial arteries. A coaxial catheter system with a 2.9-Fr steerable microcatheter and a 1.9-Fr microcatheter was advanced into the brachiocephalic artery. The right common carotid artery was selected by bending the tip of the steerable microcatheter. Coil embolization and intra-arterial cisplatin infusion after selecting each external carotid artery branch were achieved using this catheter system.</p><p><strong>Results: </strong>Cisplatin infusion and coil embolization were successful in all sessions. Arterial occlusion at the sheath insertion sites was found in 29.4% (5/17) of the distal radial arteries and 33.3% (3/9) of the conventional radial arteries. No other major complications were observed during the procedure.</p><p><strong>Conclusion: </strong>Using a 3-Fr catheter system with a steerable microcatheter through right upper limb artery access is a feasible method for RADPLAT in treating right MS-SCC.</p>","PeriodicalId":18537,"journal":{"name":"Minimally Invasive Therapy & Allied Technologies","volume":" ","pages":"53-60"},"PeriodicalIF":1.7,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141157151","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Real-time indocyanine green fluorescence imaging and navigation for cone unit laparoscopic hepatic resection of intrahepatic duct stone: a case series study. 圆锥单元腹腔镜肝切除肝内导管结石的实时吲哚菁绿荧光成像和导航:一项病例系列研究。
IF 1.7 4区 医学 Q2 SURGERY Pub Date : 2024-12-01 Epub Date: 2024-10-05 DOI: 10.1080/13645706.2024.2410369
Jianjie Hao, Donghui Cheng, Jipeng Jiang, Bangyou Zuo, Yu Zhang

Background: Intrahepatic bile duct stones, although common and benign, require varying therapeutic strategies due to their recurrent nature. Inadequate management can escalate to liver cirrhosis or cholangiocarcinoma. A surgical method merging indocyanine green fluorescence imaging (ICG-FI) with liver cone unit resection is optimal, ensuring complete lesion removal and healthy liver tissue conservation.

Method: A retrospective descriptive study was conducted on 15 patients with intrahepatic bile duct stones who were admitted to Sichuan Provincial People's Hospital from January 2021 to December 2023. All patients underwent laparoscopic anatomical liver resection guided by ICG-FI.

Results: Among the 15 patients included in the study, ten were male and five were female, with an average age of 52 years. All patients were free from underlying medical conditions. Intraoperatively, ICG-FI was good, with clear boundaries, and all patients successfully underwent surgery without any conversions to open surgery. The mean operative time was 236 ± 56 min, and the estimated blood loss was 320 ± 75 ml. Patients had a postoperative hospital stay of 5.5 ± 1.5 days. No severe complications occurred.

Conclusions: Real-time ICG-FI with anatomical liver resection is a safe and effective approach for managing intrahepatic bile duct stones.

背景:肝内胆管结石虽然是常见的良性结石,但由于其复发性,需要采取不同的治疗策略。如果处理不当,可能会发展为肝硬化或胆管癌。将吲哚菁绿荧光成像(ICG-FI)与肝锥体单元切除术相结合的手术方法是最佳选择,既能确保彻底清除病灶,又能保留健康的肝组织:方法:对四川省人民医院2021年1月至2023年12月收治的15例肝内胆管结石患者进行回顾性描述性研究。所有患者均在ICG-FI的引导下接受了腹腔镜肝脏解剖切除术:15例患者中,男性10例,女性5例,平均年龄52岁。所有患者均无基础疾病。术中,ICG-FI效果良好,边界清晰,所有患者均成功接受了手术,无一例转为开放手术。平均手术时间为 236 ± 56 分钟,估计失血量为 320 ± 75 毫升。患者术后住院时间为(5.5±1.5)天。无严重并发症发生:实时 ICG-FI 结合解剖性肝切除术是治疗肝内胆管结石的一种安全有效的方法。
{"title":"Real-time indocyanine green fluorescence imaging and navigation for cone unit laparoscopic hepatic resection of intrahepatic duct stone: a case series study.","authors":"Jianjie Hao, Donghui Cheng, Jipeng Jiang, Bangyou Zuo, Yu Zhang","doi":"10.1080/13645706.2024.2410369","DOIUrl":"10.1080/13645706.2024.2410369","url":null,"abstract":"<p><strong>Background: </strong>Intrahepatic bile duct stones, although common and benign, require varying therapeutic strategies due to their recurrent nature. Inadequate management can escalate to liver cirrhosis or cholangiocarcinoma. A surgical method merging indocyanine green fluorescence imaging (ICG-FI) with liver cone unit resection is optimal, ensuring complete lesion removal and healthy liver tissue conservation.</p><p><strong>Method: </strong>A retrospective descriptive study was conducted on 15 patients with intrahepatic bile duct stones who were admitted to Sichuan Provincial People's Hospital from January 2021 to December 2023. All patients underwent laparoscopic anatomical liver resection guided by ICG-FI.</p><p><strong>Results: </strong>Among the 15 patients included in the study, ten were male and five were female, with an average age of 52 years. All patients were free from underlying medical conditions. Intraoperatively, ICG-FI was good, with clear boundaries, and all patients successfully underwent surgery without any conversions to open surgery. The mean operative time was 236 ± 56 min, and the estimated blood loss was 320 ± 75 ml. Patients had a postoperative hospital stay of 5.5 ± 1.5 days. No severe complications occurred.</p><p><strong>Conclusions: </strong>Real-time ICG-FI with anatomical liver resection is a safe and effective approach for managing intrahepatic bile duct stones.</p>","PeriodicalId":18537,"journal":{"name":"Minimally Invasive Therapy & Allied Technologies","volume":" ","pages":"351-357"},"PeriodicalIF":1.7,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142378081","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Complete mesocolic excision (CME) impacts survival only for Stage III right-sided colon cancer: a systematic review and meta-analysis. 完全结肠系膜切除术 (CME) 仅影响 III 期右侧结肠癌患者的生存率:系统综述和荟萃分析。
IF 1.7 4区 医学 Q2 SURGERY Pub Date : 2024-12-01 Epub Date: 2024-09-25 DOI: 10.1080/13645706.2024.2405544
Kengo Hayashi, Roberto Passera, Chiara Meroni, Rebecca Dallorto, Chiara Marafante, Carlo Alberto Ammirati, Alberto Arezzo

Introduction: Complete mesocolic excision (CME) is widely adopted for its assumed superior oncological outcome. However, it's unclear if all right-sided colon cancer patients benefit from CME. The aim of this systematic review is to investigate whether CME contributes to postoperative outcomes and to determine the surgical indications for CME.

Material and methods: We searched eligible articles about CME versus non-CME procedures for right-sided colon cancer in the OVID Medline, Embase, and Cochrane CENTRAL databases, and a meta-analysis was conducted.

Results: Twenty-two articles and seven abstracts involving 8088 patients were included in this study. Among them, 3803 underwent CME and 4285 non-CME procedures. The analysis showed that CME was favoured for three-year disease-free survival (DFS) and overall survival (OS), for local, systemic, and total recurrence, and for hospital stay durations. However, increased vascular injury and longer surgery time were observed in CME. Regarding the three-year OS, the superiority of CME was observed only in Stage III. Additionally, no significant differences were observed between CME and non-CME groups regarding overall complications, 30-day readmission rates, reoperation, or postoperative mortality rates.

Conclusions: CME for right-sided colon cancer should be considered, particularly in Stage III patients, to contribute to improved oncological outcomes. However, careful attention must be paid to the increased risk of vascular injury.

导言:结肠系膜完全切除术(CME)因其假定的优越肿瘤治疗效果而被广泛采用。然而,尚不清楚是否所有右侧结肠癌患者都能从 CME 中获益。本系统性综述旨在研究 CME 是否有助于术后效果,并确定 CME 的手术适应症:我们在 OVID Medline、Embase 和 Cochrane CENTRAL 数据库中检索了符合条件的关于右侧结肠癌 CME 与非 CME 手术的文章,并进行了荟萃分析:本研究共收录了22篇文章和7篇摘要,涉及8088名患者。其中,3803 例接受了 CME,4285 例未接受 CME。分析结果表明,在三年无病生存率(DFS)和总生存率(OS)、局部复发、全身复发和总复发率以及住院时间方面,CME 更受青睐。不过,CME的血管损伤增加,手术时间延长。在三年生存率方面,仅在III期观察到CME的优越性。此外,在总体并发症、30天再入院率、再次手术率或术后死亡率方面,CME组和非CME组之间没有观察到明显差异:结论:应考虑对右侧结肠癌进行 CME 治疗,尤其是对 III 期患者,以改善肿瘤治疗效果。结论:应考虑对右侧结肠癌患者进行 CME 治疗,尤其是 III 期患者,这有助于改善肿瘤治疗效果,但必须注意血管损伤风险的增加。
{"title":"Complete mesocolic excision (CME) impacts survival only for Stage III right-sided colon cancer: a systematic review and meta-analysis.","authors":"Kengo Hayashi, Roberto Passera, Chiara Meroni, Rebecca Dallorto, Chiara Marafante, Carlo Alberto Ammirati, Alberto Arezzo","doi":"10.1080/13645706.2024.2405544","DOIUrl":"10.1080/13645706.2024.2405544","url":null,"abstract":"<p><strong>Introduction: </strong>Complete mesocolic excision (CME) is widely adopted for its assumed superior oncological outcome. However, it's unclear if all right-sided colon cancer patients benefit from CME. The aim of this systematic review is to investigate whether CME contributes to postoperative outcomes and to determine the surgical indications for CME.</p><p><strong>Material and methods: </strong>We searched eligible articles about CME versus non-CME procedures for right-sided colon cancer in the OVID Medline, Embase, and Cochrane CENTRAL databases, and a meta-analysis was conducted.</p><p><strong>Results: </strong>Twenty-two articles and seven abstracts involving 8088 patients were included in this study. Among them, 3803 underwent CME and 4285 non-CME procedures. The analysis showed that CME was favoured for three-year disease-free survival (DFS) and overall survival (OS), for local, systemic, and total recurrence, and for hospital stay durations. However, increased vascular injury and longer surgery time were observed in CME. Regarding the three-year OS, the superiority of CME was observed only in Stage III. Additionally, no significant differences were observed between CME and non-CME groups regarding overall complications, 30-day readmission rates, reoperation, or postoperative mortality rates.</p><p><strong>Conclusions: </strong>CME for right-sided colon cancer should be considered, particularly in Stage III patients, to contribute to improved oncological outcomes. However, careful attention must be paid to the increased risk of vascular injury.</p>","PeriodicalId":18537,"journal":{"name":"Minimally Invasive Therapy & Allied Technologies","volume":" ","pages":"323-333"},"PeriodicalIF":1.7,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142349868","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Correction. 更正。
IF 1.7 4区 医学 Q2 SURGERY Pub Date : 2024-12-01 Epub Date: 2024-04-14 DOI: 10.1080/13645706.2024.2343614
{"title":"Correction.","authors":"","doi":"10.1080/13645706.2024.2343614","DOIUrl":"10.1080/13645706.2024.2343614","url":null,"abstract":"","PeriodicalId":18537,"journal":{"name":"Minimally Invasive Therapy & Allied Technologies","volume":" ","pages":"396"},"PeriodicalIF":1.7,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140857186","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
In memoriam: Cristiano Germano Sigismondo Hüscher (1950-2024). 在基督教memoriam:耳Sigismondo Hüe(1950-2024)。
IF 1.7 4区 医学 Q2 SURGERY Pub Date : 2024-12-01 Epub Date: 2024-09-27 DOI: 10.1080/13645706.2024.2409268
Marco Maria Lirici
{"title":"In memoriam: Cristiano Germano Sigismondo Hüscher (1950-2024).","authors":"Marco Maria Lirici","doi":"10.1080/13645706.2024.2409268","DOIUrl":"https://doi.org/10.1080/13645706.2024.2409268","url":null,"abstract":"","PeriodicalId":18537,"journal":{"name":"Minimally Invasive Therapy & Allied Technologies","volume":"33 6","pages":"321-322"},"PeriodicalIF":1.7,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142770166","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Application value of SOMATOM Force computed tomography in assisting the preoperative localization of colorectal cancer resection surgery. SOMATOM Force 计算机断层扫描在协助结直肠癌切除手术术前定位中的应用价值。
IF 1.7 4区 医学 Q2 SURGERY Pub Date : 2024-12-01 Epub Date: 2024-10-17 DOI: 10.1080/13645706.2024.2415326
Mengru Wang

Background: The objective of this study was to assess the application value of SOMATOM Force computed tomography (CT) in assisting the preoperative localization of colorectal cancer resection surgery.

Method: Retrospectively, the medical data of 120 inpatients with colorectal cancer were collected. The Kappa consistency test was used to evaluate diagnostic consistency in the localization and staging of colorectal cancer. The diagnostic value of preoperative SOMATOM Force CT detection was analyzed.

Results: In 120 colorectal cancer patients, the accuracy of SOMATOM Force CT for preoperative localization, T staging, and N staging of colorectal cancer were 91.7% (kappa = 0.837), 88.3% (kappa = 0.772) and 91.7% (kappa = 0.773), respectively. Among 45 rectum cancer patients, there were 19 positive cases with circumferential resection margin involvement, and the accuracy of SOMATOM Force CT detection was 86.7% (kappa = 0.767). The sensitivity, specificity, positive predictive value, and negative predictive value of SOMATOM Force CT detection in evaluating the circumferential resection margin involvement of rectum cancer were 78.95%, 96.15%, 93.75%, and 86.21%, respectively.

Conclusions: There was an important application value of SOMATOM Force CT in assisting the preoperative localization and tumor staging of colorectal cancer resection surgery. There was a good diagnostic value of preoperative SOMATOM Force CT detection in evaluating the circumferential resection margin involvement of rectum cancer.

研究背景本研究旨在评估 SOMATOM Force 计算机断层扫描(CT)在协助结直肠癌切除手术术前定位方面的应用价值:方法:回顾性收集 120 名结肠直肠癌住院患者的医疗数据。方法:回顾性收集 120 例大肠癌住院患者的医疗资料,采用 Kappa 一致性检验评价大肠癌定位和分期的诊断一致性。分析了术前 SOMATOM Force CT 检测的诊断价值:在 120 名结直肠癌患者中,SOMATOM Force CT 对结直肠癌术前定位、T 分期和 N 分期的准确率分别为 91.7%(kappa = 0.837)、88.3%(kappa = 0.772)和 91.7%(kappa = 0.773)。在 45 例直肠癌患者中,有 19 例阳性病例周缘切除边缘受累,SOMATOM Force CT 检测的准确率为 86.7%(kappa = 0.767)。SOMATOM Force CT 检测评估直肠癌周缘切除边缘受累的敏感性、特异性、阳性预测值和阴性预测值分别为 78.95%、96.15%、93.75% 和 86.21%:SOMATOM Force CT 在协助结直肠癌切除手术的术前定位和肿瘤分期方面具有重要的应用价值。术前 SOMATOM Force CT 检测对评估直肠癌周缘切除边缘受累情况有很好的诊断价值。
{"title":"Application value of SOMATOM Force computed tomography in assisting the preoperative localization of colorectal cancer resection surgery.","authors":"Mengru Wang","doi":"10.1080/13645706.2024.2415326","DOIUrl":"10.1080/13645706.2024.2415326","url":null,"abstract":"<p><strong>Background: </strong>The objective of this study was to assess the application value of SOMATOM Force computed tomography (CT) in assisting the preoperative localization of colorectal cancer resection surgery.</p><p><strong>Method: </strong>Retrospectively, the medical data of 120 inpatients with colorectal cancer were collected. The Kappa consistency test was used to evaluate diagnostic consistency in the localization and staging of colorectal cancer. The diagnostic value of preoperative SOMATOM Force CT detection was analyzed.</p><p><strong>Results: </strong>In 120 colorectal cancer patients, the accuracy of SOMATOM Force CT for preoperative localization, T staging, and N staging of colorectal cancer were 91.7% (kappa = 0.837), 88.3% (kappa = 0.772) and 91.7% (kappa = 0.773), respectively. Among 45 rectum cancer patients, there were 19 positive cases with circumferential resection margin involvement, and the accuracy of SOMATOM Force CT detection was 86.7% (kappa = 0.767). The sensitivity, specificity, positive predictive value, and negative predictive value of SOMATOM Force CT detection in evaluating the circumferential resection margin involvement of rectum cancer were 78.95%, 96.15%, 93.75%, and 86.21%, respectively.</p><p><strong>Conclusions: </strong>There was an important application value of SOMATOM Force CT in assisting the preoperative localization and tumor staging of colorectal cancer resection surgery. There was a good diagnostic value of preoperative SOMATOM Force CT detection in evaluating the circumferential resection margin involvement of rectum cancer.</p>","PeriodicalId":18537,"journal":{"name":"Minimally Invasive Therapy & Allied Technologies","volume":" ","pages":"365-372"},"PeriodicalIF":1.7,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142469746","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Minimally Invasive Therapy & Allied Technologies
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1